ENTPD1 and T-cell non-Hodgkin lymphoma: Finally, no significant difference in CD39 expression was noticed between a group of rare CTCL (n = 8, including two primary cutaneous gamma‐delta T cell lymphomas, three extranodal natural killer/T cell lymphomas and three primary cutaneous peripheral T cell lymphoma, no other specification) and the ISD control group.